How We Have Helped

 
OSOD has conducted over 2000+ studies with 7+ approvals both published and non-disclosed, in our 30-year history spanning the development process from initial iterative investigative studies, to chronic GLP-compliant safety studies, to advising on clinical testing strategy.

The eye is often at the forefront of innovatative therapies and we have been involved with many.  Our skilled ophthalmologists and technicans have the ability to administer therapies and evaluate their safety in all laboratory animal species from rodents, to minipigs, to nonhuman primates.

As a primary preclinical partner for the development of approved ophthalmic therapies and clinical testing approval for many others, we know our approach works.